Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2316-21. doi: 10.1073/pnas.96.5.2316.

Abstract

Epithelial (E)-cadherin and its associated cytoplasmic proteins (alpha-, beta-, and gamma-catenins) are important mediators of epithelial cell-cell adhesion and intracellular signaling. Much evidence exists suggesting a tumor/invasion suppressor role for E-cadherin, and loss of expression, as well as mutations, has been described in a number of epithelial cancers. To investigate whether E-cadherin gene (CDH1) mutations occur in colorectal cancer, we screened 49 human colon carcinoma cell lines from 43 patients by single-strand conformation polymorphism (SSCP) analysis and direct sequencing. In addition to silent changes, polymorphisms, and intronic variants in a number of the cell lines, we detected frameshift single-base deletions in repeat regions of exon 3 (codons 120 and 126) causing premature truncations at codon 216 in four replication-error-positive (RER+) cell lines (LS174T, HCT116, GP2d, and GP5d) derived from 3 patients. In LS174T such a mutation inevitably contributes to its lack of E-cadherin protein expression and function. Transfection of full-length E-cadherin cDNA into LS174T cells enhanced intercellular adhesion, induced differentiation, retarded proliferation, inhibited tumorigenicity, and restored responsiveness to the migratory effects induced by the motogenic trefoil factor 2 (human spasmolytic polypeptide). These results indicate that, although inactivating E-cadherin mutations occur relatively infrequently in colorectal cancer cell lines overall (3/43 = 7%), they are more common in cells with an RER+ phenotype (3/10 = 30%) and may contribute to the dysfunction of the E-cadherin-catenin-mediated adhesion/signaling system commonly seen in these tumors. These results also indicate that normal E-cadherin-mediated cell adhesion can restore the ability of colonic tumor cells to respond to trefoil factor 2.

MeSH terms

  • Animals
  • Base Pairing
  • Cadherins / genetics*
  • Cadherins / physiology
  • Cell Adhesion / drug effects
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology*
  • Colorectal Neoplasms
  • DNA Replication / genetics
  • Exons
  • Female
  • Frameshift Mutation
  • Genetic Variation
  • Growth Substances / pharmacology*
  • Humans
  • Introns
  • Mice
  • Mice, Nude
  • Mucins*
  • Muscle Proteins*
  • Mutation*
  • Neuropeptides*
  • Peptides / pharmacology*
  • Point Mutation
  • Polymorphism, Genetic
  • Polymorphism, Single-Stranded Conformational*
  • Recombinant Proteins / biosynthesis
  • Sequence Deletion
  • Transfection
  • Transplantation, Heterologous
  • Trefoil Factor-2
  • Trefoil Factor-3
  • Tumor Cells, Cultured

Substances

  • Cadherins
  • Growth Substances
  • Mucins
  • Muscle Proteins
  • Neuropeptides
  • Peptides
  • Recombinant Proteins
  • TFF2 protein, human
  • TFF3 protein, rat
  • Tff2 protein, rat
  • Trefoil Factor-2
  • Trefoil Factor-3